Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

OPDIVO 10 mg/mL concentrate for solution for infusion

Active Ingredient:
nivolumab
Company:  
Bristol Myers Squibb Pharmaceuticals limited See contact details
ATC code: 
L01FF01
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Healthcare Professionals (SmPC) Patient Leaflet (PIL) Risk Materials Product Information HCP Med Info
{arrow_left}
{arrow_right}
Information for Healthcare Professionals (HCPs): Nivolumab HCP Guide (Risk Minimisation Material) *Retirement*

The nivolumab HCP Guide (Title: Important Risk Minimisation Information for Healthcare Professionals, Version April 2019, 1506UK1900193-01) has been retired as a nivolumab risk minimisation material.
Bristol Myers Squibb Pharmaceuticals limited
Company image
Address
Bristol-Myers Squibb, ARC Uxbridge, Sanderson Road, New Denham, Denham, Buckinghamshire, UB8 1DH, UK
Telephone
+44 (0)1895 523 000
Medical Information e-mail
[email protected]
Medical Information Direct Line
+44 (0) 800 731 1736
Medical Information Website
https://www.bmsmedinfo.co.uk/